Carregant...
New horizons for the treatment of severe, eosinophilic asthma: benralizumab, a novel precision biologic
In the last decades, the increasing evidence concerning inflammation mechanisms underlying severe eosinophilic asthma has highlighted new potential therapeutic targets and has paved the way to new selective biologic drugs. Understanding the mechanism of action and the clinical outcomes of a particul...
Guardat en:
| Publicat a: | Biologics |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Dove
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6535408/ https://ncbi.nlm.nih.gov/pubmed/31190733 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BTT.S157183 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|